Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".
about
Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-capAntiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancerDevelopment of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.Delivery of antibody mimics into mammalian cells via anthrax toxin protective antigenThe SH2 domain of Abl kinases regulates kinase autophosphorylation by controlling activation loop accessibility.
P2860
Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".
@en
Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".
@nl
type
label
Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".
@en
Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".
@nl
prefLabel
Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".
@en
Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable".
@nl
P2860
P50
P356
P1433
P1476
Targeting allosteric regulatory modules in oncoproteins: "drugging the undruggable"
@en
P2093
Florian Grebien
P2860
P304
P356
10.18632/ONCOTARGET.354
P407
P577
2011-11-01T00:00:00Z